July 3 (Reuters) - Beam Therapeutics Inc ( BEAM ):
* BEAM THERAPEUTICS INC ( BEAM ) - BUYS EARLY-STAGE LIFE SCIENCES
COMPANY -
SEC FILING
* BEAM THERAPEUTICS INC ( BEAM ) - POTENTIAL ADDITIONAL PAYMENTS UP
TO $89
MILLION - SEC FILING
* BEAM THERAPEUTICS INC ( BEAM ) - MAXIMUM OF 5.2 MILLION MILESTONE
SHARES
ISSUABLE AT $17.01 PER SHARE - SEC FILING
Further company coverage: